Filing Details
- Accession Number:
- 0001209191-22-002451
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 17:08:46
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2022-01-07 17:08:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-01 | 75 | $4.14 | 181,260 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-02 | 75 | $3.84 | 181,335 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-03 | 75 | $4.47 | 181,410 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-06 | 75 | $4.46 | 181,485 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-07 | 75 | $5.61 | 181,560 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-08 | 75 | $6.15 | 181,635 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-09 | 75 | $5.81 | 181,710 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-10 | 75 | $4.82 | 181,785 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-13 | 200 | $4.36 | 181,985 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-14 | 200 | $4.28 | 182,185 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-15 | 200 | $4.29 | 182,385 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-16 | 240 | $4.53 | 182,625 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-17 | 240 | $4.17 | 182,865 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-20 | 276 | $4.33 | 183,141 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
